CYstic Fibrosis bacterioPHage Study at Yale (CYPHY): A Single-site, Randomized, Double-blind, Placebo-controlled Study of Bacteriophage Therapy YPT-01 for Pseudomonas Aeruginosa Infections in Adults With Cystic Fibrosis
Latest Information Update: 25 Jun 2024
At a glance
- Drugs YPT-01 (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- Acronyms CYPHY
- 22 May 2024 Results assessing phage therapy safety and effects on sputum P. aeruginosa, presented at the 120th International Conference of the American Thoracic Society.
- 27 Oct 2023 Status changed from active, no longer recruiting to completed.
- 13 Dec 2022 Status changed from recruiting to active, no longer recruiting.